Goldmann perimetry in acromegaly: A survey of 307 cases from 1951 through 1996

Ophthalmology

Volumn 107, Issue 5, 2000, Pages 991-997

  Rivoal, Olivier ^a   Brézin, Antoine P ^a   Feldman Billard, Sylvie ^b   Luton, Jean Pierre ^a  

^a Institut Cochin   (France)

^b CENTRE HOSPITALIER NATIONAL D OPHTALMOLOGIE DES QUINZE VINGTS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE;

ACROMEGALY; ADULT; AGED; ARTICLE; CLINICAL EXAMINATION; EMPTY SELLA SYNDROME; FEMALE; GROWTH HORMONE BLOOD LEVEL; HUMAN; HYPOPHYSIS ADENOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; PERIMETRY; PRIORITY JOURNAL; RADIODIAGNOSIS; RETROSPECTIVE STUDY; SEX RATIO; TUMOR VOLUME; VISUAL FIELD DEFECT;

EID: 0033801266     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(00)00060-9     Document Type: Article

References (50)

1. Acromegaly
2. Anterior pituitary gland
3. Growth-hormone and prolactin excess
4. Clinical review 22. Therapeutic options in acromegaly
5. Clinical features and differential diagnosis of pituitary tumours with emphasis on acromegaly
6. Acromegaly. Clinical and biochemical features in 500 patients
7. Pituitary tumors. Current concepts in diagnosis and management
8. Acromegaly
9. Ophthalmologic changes produced by pituitary tumors
10. Patterns of visual loss associated with pituitary macroadenomas
11. Distortions of the visual fields in cases of brain tumour. Chiasmal lesions, with especial reference to bitemporal hemianopsia
12. Chiasmal visual fields
13. A radio-immunoelectrophoretic assay for human growth hormone
14. Transsphenoidal hypophysectomy
15. Indications of the transsphenoidal approach to pituitary adenomas. Experience with 165 operations
16. Factors predicting pituitary adenoma invasiveness in acromegalic patients
17. Surgical outcome after repeated transsphenoidal surgery in acromegaly
18. Results of transsphenoidal microsurgery for growth hormone-secreting pituitary adenoma in a series of 214 patients
19. Which factors predict the results of pituitary surgery in acromegaly?
20. Acromegaly: Reassessment of the long-term therapeutic effectiveness of transsphenoidal pituitary surgery
21. The sensitivity of growth hormone secretion to medical treatment in acromegalic patients: Influence of age and sex
22. Pituitary tumors and the ophthalmologist
23. Interrelationships between tumour size, age, plasma growth hormone and incidence of extracellular extension in acromegalic patients
24. Evaluation of selective transsphenoidal adenomectomy by endocrinological testing and somatomedin-C measurement in acromegaly
25. Transsphenoidal surgery for acromegaly - Long-term results in 100 patients
26. Erstsymptome und Anamnesezeiten bei 517 Patienten mit Hypophysenadenomen
27. Visual status after transsphenoidal surgery at the Mayo Clinic, 1971-1982
28. Evolution campimetrique apres interventions des adenomes hypophysaires (A propos de 190 cas)
29. Visual outcome after surgical removal of craniopharyngiomas
30. Serum growth hormone levels and size of pituitary tumour in untreated acromegaly
31. Prognostic factors of radiotherapy alone in the management of pituitary adenomas
32. Prognostic factors and results of surgery and postoperative irradiation in the management of pituitary adenomas
33. Visual outcomes of pituitary adenoma surgery. St Vincent's Hospital 1968-1987
34. Visual field defects in patients with pituitary adenomas
35. Pituitary adenomas with ocular manifestations. Incidence of cases and clinical findings 1946-1984
36. Pituitary tumor volume as a predictor of postoperative visual field recovery. Quantitative analysis using automated static perimetry and computed tomography morphometry
37. Empty sella syndrome with visual field disturbance
38. Visual disturbances in patients with pituitary adenoma
39. Vascular architecture of the human optic chiasma and bitemporal hemianopia
40. Visual recovery after transsphenoidal removal of pituitary adenomas
41. Results of radiotherapy in the treatment of acromegaly: Lack of ophthalmologic complications
42. Recovery of vision following transsphenoidal surgery for pituitary adenomas
43. Visual outcome after transsphenoidal surgery for pituitary adenomas
44. A clinical comparison of visual field testing with a new automated perimeter, the Humphrey Field Analyzer, and the Goldmann perimeter
45. Effectiveness of computer-assisted perimetry in the diagnosis of pituitary adenomas
46. Effectiveness of computer-assisted perimetry in the follow-up of patients with pituitary microadenoma responsive to medical treatment
47. Automated perimetry detects visual field loss before manual Goldmann perimetry
48. Pituitary adenomas: Automatic static perimetry and Goldmann perimetry. A comparative study of 345 visual field charts